Teams mounting separate clinical trials at Vanderbilt University Medical Center sought to form research cohorts on two rare, life-threatening adverse drug reactions: drug-induced torsade de pointes (an arrythmia) and Stevens-Johnson syndrome/toxic epidermal necrolysis.
In a paper in the Journal of the American Medical Informatics Association, Sarah DeLozier, Joshua Denny, MD, MS, FACMI, and colleagues* report an automated solution for identifying candidates for these trials.
To access the full article, click here.
*Additional authors include Peter Speltz; Leigh Anne Tang; Janey Wang, MS, MEng; Joshua Smith, PhD; Dario Giuse, PhD; Dan Roden, MD; Jason Brito; Elizabeth Phillips, MD; Kristina Williams, MSN; Teresa Strickland, RN; and Giovanni Davogustto, MD. The study was supported in part by the National Institutes of Health (GM115305).